Articles by Jonathan Randles, David Voreacos and Steven Church

J&J Loses Latest Legal Bid to Revive Talc Bankruptcy Strategy

Johnson & Johnson lost its bid in a federal appeals court to revive a plan to settle tens of thousands of talc cancer lawsuits by placing a subsidiary into bankruptcy. The ruling Thursday upheld a bankruptcy judge’s dismissal last year …

SPAC Mania’s Ugly End Yields $46 Billion of Investor Losses in 2023

Wall Street’s affair with blank-check firms, the finance fad that pushed companies onto the stock market during the COVID-19 pandemic, ended this year with a string of big bankruptcies and even bigger losses for shareholders. At least 21 firms that …

Vesttoo Creditors Say Bankrupt Israeli Insurance Startup Should Liquidate

Vesttoo Ltd. creditors are seeking to take control of the bankrupt Israeli startup’s court proceedings, arguing the company should liquidate following revelations that its former executives helped create fraudulent documents that supported transactions on its platform. A committee of Vesttoo …

Mallinckrodt Gets Second Extension on Opioid Settlement Payment

Mallinckrodt Plc has for the second time reached an agreement to further delay a $200 million opioid settlement payment that was due earlier this month as the company continues to evaluate its options for addressing its debt load. The drugmaker …

A $1.7 Billion Opioid Settlement Is at Risk of Falling Apart

A major US opioid settlement is on the verge of unraveling. Mallinckrodt Plc, the drugmaker that first began producing morphine and codeine in 1898, owes states, hospitals, tribes, individuals and others hurt by the opioid crisis $200 million by the …